Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2010 2
2011 1
2012 16
2013 7
2014 8
2015 3
2016 5
2017 9
2018 3
2019 5
2020 8
2021 9
2022 4
2023 6
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31643690

77 results

Results by year

Filters applied: . Clear all
Page 1
Multiple Sclerosis Agents.
[No authors listed] [No authors listed] 2022 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Sep 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643690 Free Books & Documents. Review.
Drugs for multiple sclerosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Mar 22;63(1620):42-48. Med Lett Drugs Ther. 2021. PMID: 33976089 Review. No abstract available.
Ozanimod (Zeposia) for multiple sclerosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Aug 24;62(1605):132-134. Med Lett Drugs Ther. 2020. PMID: 32970043 Review. No abstract available.
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
Tramacere I, Virgili G, Perduca V, Lucenteforte E, Benedetti MD, Capobussi M, Castellini G, Frau S, Gonzalez-Lorenzo M, Featherstone R, Filippini G. Tramacere I, et al. Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD012186. doi: 10.1002/14651858.CD012186.pub2. Cochrane Database Syst Rev. 2023. PMID: 38032059 Free PMC article. Review.
Cladribine (Mavenclad) for multiple sclerosis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jul 29;61(1577):118-120. Med Lett Drugs Ther. 2019. PMID: 31381552 Review. No abstract available.
77 results